Last Updated : March 19, 2024
Details
FilesGeneric Name:
NovoTTF-200A
Project Status:
Completed
Therapeutic Area:
Supratentorial glioblastoma (GBM)
Manufacturer:
Novocure Canada Inc.
Call for patient/clinician input open:
Brand Name:
Optune
Project Line:
Health Technology Review
Project Sub Line:
Optimal Use
Project Number:
OP0554-000
Call for patient/clinician input closed:
To enhance the quality and relevance of this work, we are engaging people with extensive personal and/or professional experience within the Canadian health system.
| Call for patient/clinician input open | July 13, 2023 |
|---|---|
| Call for patient/clinician input closed | September 1, 2023 |
| Submission received | August 18, 2023 |
| Submission accepted | September 1, 2023 |
| Review initiated | September 5, 2023 |
| Draft recommendation posted for stakeholder feedback | February 1, 2024 |
| End of feedback period | February 15, 2023 |
Files
Last Updated : March 19, 2024